These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6589763)

  • 21. Host-induced cell wall remodeling impairs opsonophagocytosis of
    Ledger EVK; Edwards AM
    mBio; 2024 Aug; 15(8):e0164324. PubMed ID: 39041819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of anticapsular antibodies on neutrophil phagocytosis of Staphylococcus aureus.
    Guidry AJ; Oliver SP; Squiggins KE; Erbe EF; Dowlen HH; Hambleton CN; Berning LM
    J Dairy Sci; 1991 Oct; 74(10):3360-9. PubMed ID: 1744265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum complement factor I decreases Staphylococcus aureus phagocytosis.
    Cunnion KM; Buescher ES; Hair PS
    J Lab Clin Med; 2005 Nov; 146(5):279-86. PubMed ID: 16242527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Staphylococcus aureus cell wall antigens in the stimulation of delayed hypersensitivity after staphylococcal infection.
    Easmon CS; Glynn AA
    Infect Immun; 1978 Jan; 19(1):341-2. PubMed ID: 75189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipoteichoic acid from Staphylococcus aureus increases matrix metalloproteinase 9 expression in RAW 264.7 macrophages: modulation by A2A and A2B adenosine receptors.
    Souza LF; Jardim FR; Sauter IP; Souza MM; Barreto F; Margis R; Bernard EA
    Mol Immunol; 2009 Feb; 46(5):937-42. PubMed ID: 18950865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to cell wall peptidoglycan of Staphylococcus aureus in patients with serious staphylococcal infections.
    Verbrugh HA; Peters R; Rozenberg-Arska M; Peterson PK; Verhoef J
    J Infect Dis; 1981 Jul; 144(1):1-9. PubMed ID: 7264368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice.
    Collins LV; Kristian SA; Weidenmaier C; Faigle M; Van Kessel KP; Van Strijp JA; Götz F; Neumeister B; Peschel A
    J Infect Dis; 2002 Jul; 186(2):214-9. PubMed ID: 12134257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of antibodies to preparations of Staphylococcus aureus peptidoglycan, teichoic acids and polysaccharide in patients' sera].
    Vaneeva NP; Mezhevitinov VB; Bagirova NS
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Aug; (8):85-8. PubMed ID: 3318232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies to Staphylococcus aureus peptidoglycan and lipoteichoic acid in sera from blood donors and patients with staphylococcal infections.
    Wergeland H; Endresen C; Natås OB; Aasjord P; Oeding P
    Acta Pathol Microbiol Immunol Scand B; 1984 Oct; 92(5):265-9. PubMed ID: 6516850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovine opsonins for Staphylococcus aureus cell wall and pseudocapsule.
    Watson DL
    Res Vet Sci; 1989 Jan; 46(1):84-9. PubMed ID: 2784216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential role of neutrophil Fcgamma receptor IIIB (CD16) in phagocytosis, bacterial killing, and responses to immune complexes.
    Fossati G; Moots RJ; Bucknall RC; Edwards SW
    Arthritis Rheum; 2002 May; 46(5):1351-61. PubMed ID: 12115243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathogenesis of Staphylococcus aureus infections].
    Cotar AI
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(2):69-77. PubMed ID: 20422921
    [No Abstract]   [Full Text] [Related]  

  • 33. Neutrophil chemotactic activity of peptidoglycan. A comparison between Staphylococcus aureus and Staphylococcus epidermidis.
    Riber U; Espersen F; Wilkinson BJ; Kharazmi A
    APMIS; 1990 Oct; 98(10):881-6. PubMed ID: 2245008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial evasion of innate host defenses--the Staphylococcus aureus lesson.
    Fedtke I; Götz F; Peschel A
    Int J Med Microbiol; 2004 Sep; 294(2-3):189-94. PubMed ID: 15493829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anti-inflammatory activities of Staphylococcus aureus.
    Chavakis T; Preissner KT; Herrmann M
    Trends Immunol; 2007 Sep; 28(9):408-18. PubMed ID: 17681885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surface Glycopolymers Are Crucial for In Vitro Anti-Wall Teichoic Acid IgG-Mediated Complement Activation and Opsonophagocytosis of Staphylococcus aureus.
    Lee JH; Kim NH; Winstel V; Kurokawa K; Larsen J; An JH; Khan A; Seong MY; Lee MJ; Andersen PS; Peschel A; Lee BL
    Infect Immun; 2015 Nov; 83(11):4247-55. PubMed ID: 26283333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
    Cunnion KM; Benjamin DK; Hester CG; Frank MM
    J Lab Clin Med; 2004 Jun; 143(6):358-65. PubMed ID: 15192652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Staphylococcus aureus, the Particulate State of the Cell Envelope Is Required for the Efficient Induction of Host Defense Responses.
    Kim B; Jiang T; Bae JH; Yun HS; Jang SH; Kim JH; Kim JD; Hur JH; Shibata K; Kurokawa K; Jung Y; Peschel A; Bae T; Lee BL
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31548327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A morphological study of the role of phagocytes in the clearance of Staphylococcus aureus from the lung.
    Lipscomb MF; Onofrio JM; Nash EJ; Pierce AK; Toews GB
    J Reticuloendothel Soc; 1983 Jun; 33(6):429-42. PubMed ID: 6854558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human alveolar macrophage cytophilic immunoglobulin G-mediated phagocytosis of protein A-positive staphylococci.
    Verbrugh HA; Hoidal JR; Nguyen BY; Verhoef J; Quie PG; Peterson PK
    J Clin Invest; 1982 Jan; 69(1):63-74. PubMed ID: 7054243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.